ROKIT Healthcare Inc.

₩17,360As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:376900Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (64.43%)
Biological Products, Except Diagnostic Substances
Beta (5Y) —
PE TTM —
TSR TTM (54.01%)
Mkt cap ₩301.4B
ROIC (27.50%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩17,488
0.74%
4.64%
Hold 12|9|11|6|6
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
257.52
278.36
265.44
264.60
21.53%
19.53%
9.29%
(2.31%)
Revenue₩B
15.94
16.16
15.93
16.53
8.94%
6.74%
7.38%
8.77%
Peers (US$222.2M)
Cap (US$)
PE
236.3M
—
217.0M
—
222.5M
—
Capital
TTM
5Y
10Y
Leveragex
0.720
0.067
0.065
EBIT/Intx
6.024
0.894
0.751
Own earn%
(179.42)
(77.73)
(68.63)
Sh yield%
34.74
21.21
20.78
Owners
Insiders/Inst%
10.21
37.31
Short interest%
3.50
SBC / revenue%
5.33
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
30–35
$1 testx
0.0
Incr. ROIC%
4